Validation Data Gallery
|Positive WB detected in||Jurkat cells, mouse spleen tissue, Raji cells, HL-60 cells, A431 cells, human liver tissue, HEK-293T cells, human brain tissue, K-562 cells, MCF-7 cells, HeLa cells|
|Positive IP detected in||Raji cells|
|Positive IF detected in||MCF-7 cells|
|Positive FC detected in||Ramos cells|
|Western Blot (WB)||WB : 1:1000-1:8000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:2000 for WB|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
16225-1-AP targets MCL1 in WB, IP, IHC, IF, FC, ELISA applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||human, mouse, rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||MCL1 fusion protein Ag10397|
|Full Name||myeloid cell leukemia sequence 1 (BCL2-related)|
|Calculated molecular weight||350 aa, 37 kDa|
|Observed molecular weight||35-40 kDa|
|GenBank accession number||BC107735|
|Gene ID (NCBI)||4170|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
MCL-1 is an anti-apoptotic member of the Bcl-2 family originally isolated from the ML-1 human myeloid leukemia cell line. Similar to BCL2 and BCL2L1, MCL1 can interact with BAX and/or BAK1 to inhibit mitochondria-mediated apoptosis. Mcl-1 is critical for the proliferation and survival of myeloma cells in vitro, and overexpression of Mcl-1 protein in myeloma cells is associated with relapse and short event-free survival in multiple myeloma patients. Recent studies show that MCL-1 is upregulated in numerous haematological and solid tumour malignancies. Therefore, MCL-1 has been suggested as a potential new therapeutic target. MCL-1 can be alternatively spliced into a long form (MCL-1L, 40 kDa) or a short form (MCL-1S, 30 kDa). (PMID: 15467463, PMID: 15147382)
|Product Specific Protocols|
|WB protocol for MCL1 antibody 16225-1-AP||Download protocol|
|IF protocol for MCL1 antibody 16225-1-AP||Download protocol|
|IP protocol for MCL1 antibody 16225-1-AP||Download protocol|
|FC protocol for MCL1 antibody 16225-1-AP||Download protocol|
|Click here to view our Standard Protocols|
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.
Small-molecule suppression of calpastatin degradation reduces neuropathology in models of Huntington's disease.
IFN-β is a macrophage-derived effector cytokine facilitating the resolution of bacterial inflammation.
The LIV-1-GRPEL1 axis adjusts cell fate during anti-mitotic agent-damaged mitosis.
USP9X regulates centrosome duplication and promotes breast carcinogenesis.
Aging (Albany NY)
Melatonin induces cell cycle arrest and suppresses tumor invasion in urinary bladder urothelial carcinoma
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
Eya (Verified Customer) (07-06-2021)
the bands appear very clear